Quantification	O
of	O
intact	O
plasma	B:C0032105
angiotensinogen	O
consisting	O
of	O
oxidized	O
and	O
reduced	O
conformations	I:C0033625
using	O
a	O
modified	O
ELISA	O
.	O

Quantification	O
of	O
intact	O
plasma	O
angiotensinogen	B:C0003017
consisting	O
of	O
oxidized	O
and	O
reduced	O
conformations	I:C0033625
using	O
a	O
modified	O
ELISA	O
.	O

Quantification	O
of	O
intact	O
plasma	O
angiotensinogen	O
consisting	O
of	O
oxidized	O
and	O
reduced	B:C0033625
conformations	I:C0033625
using	O
a	O
modified	O
ELISA	O
.	O

Quantification	O
of	O
intact	O
plasma	O
angiotensinogen	O
consisting	O
of	O
oxidized	O
and	O
reduced	O
conformations	I:C0033625
using	O
a	O
modified	O
ELISA	B:C0014441
.	O

The	O
pleiotropic	O
actions	O
of	O
the	O
renin-	B:C0035096
angiotensin	I:C0035096
system	I:C0035096
(	O
renin-	O
angiotensin	I:C0035096
system	I:C0035096
)	O
depend	O
on	O
the	O
availability	O
of	O
angiotensinogen	O
(	O
angiotensinogen	O
)	O
which	O
generates	O
angiotensin	O
I	I:C0003006
(	O
angiotensin	O
I	I:C0003006
)	O
when	O
cleaved	O
by	O
renin	O
.	O

The	O
pleiotropic	O
actions	O
of	O
the	O
renin-	O
angiotensin	I:C0035096
system	I:C0035096
(	O
renin-	B:C0035096
angiotensin	I:C0035096
system	I:C0035096
)	O
depend	O
on	O
the	O
availability	O
of	O
angiotensinogen	O
(	O
angiotensinogen	O
)	O
which	O
generates	O
angiotensin	O
I	I:C0003006
(	O
angiotensin	O
I	I:C0003006
)	O
when	O
cleaved	O
by	O
renin	O
.	O

The	O
pleiotropic	O
actions	O
of	O
the	O
renin-	O
angiotensin	I:C0035096
system	I:C0035096
(	O
renin-	O
angiotensin	I:C0035096
system	I:C0035096
)	O
depend	O
on	O
the	O
availability	O
of	O
angiotensinogen	B:C0003017
(	O
angiotensinogen	O
)	O
which	O
generates	O
angiotensin	O
I	I:C0003006
(	O
angiotensin	O
I	I:C0003006
)	O
when	O
cleaved	O
by	O
renin	O
.	O

The	O
pleiotropic	O
actions	O
of	O
the	O
renin-	O
angiotensin	I:C0035096
system	I:C0035096
(	O
renin-	O
angiotensin	I:C0035096
system	I:C0035096
)	O
depend	O
on	O
the	O
availability	O
of	O
angiotensinogen	O
(	O
angiotensinogen	B:C0003017
)	O
which	O
generates	O
angiotensin	O
I	I:C0003006
(	O
angiotensin	O
I	I:C0003006
)	O
when	O
cleaved	O
by	O
renin	O
.	O

The	O
pleiotropic	O
actions	O
of	O
the	O
renin-	O
angiotensin	I:C0035096
system	I:C0035096
(	O
renin-	O
angiotensin	I:C0035096
system	I:C0035096
)	O
depend	O
on	O
the	O
availability	O
of	O
angiotensinogen	O
(	O
angiotensinogen	O
)	O
which	O
generates	O
angiotensin	B:C0003006
I	I:C0003006
(	O
angiotensin	O
I	I:C0003006
)	O
when	O
cleaved	O
by	O
renin	O
.	O

The	O
pleiotropic	O
actions	O
of	O
the	O
renin-	O
angiotensin	I:C0035096
system	I:C0035096
(	O
renin-	O
angiotensin	I:C0035096
system	I:C0035096
)	O
depend	O
on	O
the	O
availability	O
of	O
angiotensinogen	O
(	O
angiotensinogen	O
)	O
which	O
generates	O
angiotensin	O
I	I:C0003006
(	O
angiotensin	B:C0003006
I	I:C0003006
)	O
when	O
cleaved	O
by	O
renin	O
.	O

The	O
pleiotropic	O
actions	O
of	O
the	O
renin-	O
angiotensin	I:C0035096
system	I:C0035096
(	O
renin-	O
angiotensin	I:C0035096
system	I:C0035096
)	O
depend	O
on	O
the	O
availability	O
of	O
angiotensinogen	O
(	O
angiotensinogen	O
)	O
which	O
generates	O
angiotensin	O
I	I:C0003006
(	O
angiotensin	O
I	I:C0003006
)	O
when	O
cleaved	B:C0205242
by	O
renin	O
.	O

The	O
pleiotropic	O
actions	O
of	O
the	O
renin-	O
angiotensin	I:C0035096
system	I:C0035096
(	O
renin-	O
angiotensin	I:C0035096
system	I:C0035096
)	O
depend	O
on	O
the	O
availability	O
of	O
angiotensinogen	O
(	O
angiotensinogen	O
)	O
which	O
generates	O
angiotensin	O
I	I:C0003006
(	O
angiotensin	O
I	I:C0003006
)	O
when	O
cleaved	O
by	O
renin	B:C0035094
.	O

Thus	O
,	O
quantification	O
of	O
the	O
intact	O
angiotensinogen	B:C0003017
(	O
intact	O
AGT	I:C0003017
)	O
concentrations	O
is	O
important	O
to	O
evaluate	O
the	O
actual	O
renin	O
substrate	I:C0003017
available	O
.	O

Thus	O
,	O
quantification	O
of	O
the	O
intact	O
angiotensinogen	O
(	O
intact	B:C0003017
AGT	I:C0003017
)	O
concentrations	O
is	O
important	O
to	O
evaluate	O
the	O
actual	O
renin	O
substrate	I:C0003017
available	O
.	O

Thus	O
,	O
quantification	O
of	O
the	O
intact	O
angiotensinogen	O
(	O
intact	O
AGT	I:C0003017
)	O
concentrations	O
is	O
important	O
to	O
evaluate	O
the	O
actual	O
renin	B:C0003017
substrate	I:C0003017
available	O
.	O

The	O
intact	B:C0003017
AGT	I:C0003017
conformation	O
exists	O
as	O
oxidized	O
AGT	I:C0003017
(	O
oxidized	O
AGT	I:C0003017
)	O
and	O
reduced	O
AGT	I:C0003017
(	O
reduced	O
AGT	I:C0003017
)	O
in	O
a	O
disulfide	O
bond	I:C1511997
,	O
and	O
oxidized	O
AGT	I:C0003017
has	O
a	O
higher	O
affinity	O
for	O
renin	O
,	O
which	O
may	O
exacerbate	O
renin-angiotensin	O
system	I:C0035096
-	O
associated	O
diseases	I:C0243083
.	O

The	O
intact	O
AGT	I:C0003017
conformation	B:C0033625
exists	O
as	O
oxidized	O
AGT	I:C0003017
(	O
oxidized	O
AGT	I:C0003017
)	O
and	O
reduced	O
AGT	I:C0003017
(	O
reduced	O
AGT	I:C0003017
)	O
in	O
a	O
disulfide	O
bond	I:C1511997
,	O
and	O
oxidized	O
AGT	I:C0003017
has	O
a	O
higher	O
affinity	O
for	O
renin	O
,	O
which	O
may	O
exacerbate	O
renin-angiotensin	O
system	I:C0035096
-	O
associated	O
diseases	I:C0243083
.	O

The	O
intact	O
AGT	I:C0003017
conformation	O
exists	O
as	O
oxidized	B:C0003017
AGT	I:C0003017
(	O
oxidized	O
AGT	I:C0003017
)	O
and	O
reduced	O
AGT	I:C0003017
(	O
reduced	O
AGT	I:C0003017
)	O
in	O
a	O
disulfide	O
bond	I:C1511997
,	O
and	O
oxidized	O
AGT	I:C0003017
has	O
a	O
higher	O
affinity	O
for	O
renin	O
,	O
which	O
may	O
exacerbate	O
renin-angiotensin	O
system	I:C0035096
-	O
associated	O
diseases	I:C0243083
.	O

The	O
intact	O
AGT	I:C0003017
conformation	O
exists	O
as	O
oxidized	O
AGT	I:C0003017
(	O
oxidized	B:C0003017
AGT	I:C0003017
)	O
and	O
reduced	O
AGT	I:C0003017
(	O
reduced	O
AGT	I:C0003017
)	O
in	O
a	O
disulfide	O
bond	I:C1511997
,	O
and	O
oxidized	O
AGT	I:C0003017
has	O
a	O
higher	O
affinity	O
for	O
renin	O
,	O
which	O
may	O
exacerbate	O
renin-angiotensin	O
system	I:C0035096
-	O
associated	O
diseases	I:C0243083
.	O

The	O
intact	O
AGT	I:C0003017
conformation	O
exists	O
as	O
oxidized	O
AGT	I:C0003017
(	O
oxidized	O
AGT	I:C0003017
)	O
and	O
reduced	B:C0003017
AGT	I:C0003017
(	O
reduced	O
AGT	I:C0003017
)	O
in	O
a	O
disulfide	O
bond	I:C1511997
,	O
and	O
oxidized	O
AGT	I:C0003017
has	O
a	O
higher	O
affinity	O
for	O
renin	O
,	O
which	O
may	O
exacerbate	O
renin-angiotensin	O
system	I:C0035096
-	O
associated	O
diseases	I:C0243083
.	O

The	O
intact	O
AGT	I:C0003017
conformation	O
exists	O
as	O
oxidized	O
AGT	I:C0003017
(	O
oxidized	O
AGT	I:C0003017
)	O
and	O
reduced	O
AGT	I:C0003017
(	O
reduced	B:C0003017
AGT	I:C0003017
)	O
in	O
a	O
disulfide	O
bond	I:C1511997
,	O
and	O
oxidized	O
AGT	I:C0003017
has	O
a	O
higher	O
affinity	O
for	O
renin	O
,	O
which	O
may	O
exacerbate	O
renin-angiotensin	O
system	I:C0035096
-	O
associated	O
diseases	I:C0243083
.	O

The	O
intact	O
AGT	I:C0003017
conformation	O
exists	O
as	O
oxidized	O
AGT	I:C0003017
(	O
oxidized	O
AGT	I:C0003017
)	O
and	O
reduced	O
AGT	I:C0003017
(	O
reduced	O
AGT	I:C0003017
)	O
in	O
a	O
disulfide	B:C1511997
bond	I:C1511997
,	O
and	O
oxidized	O
AGT	I:C0003017
has	O
a	O
higher	O
affinity	O
for	O
renin	O
,	O
which	O
may	O
exacerbate	O
renin-angiotensin	O
system	I:C0035096
-	O
associated	O
diseases	I:C0243083
.	O

The	O
intact	O
AGT	I:C0003017
conformation	O
exists	O
as	O
oxidized	O
AGT	I:C0003017
(	O
oxidized	O
AGT	I:C0003017
)	O
and	O
reduced	O
AGT	I:C0003017
(	O
reduced	O
AGT	I:C0003017
)	O
in	O
a	O
disulfide	O
bond	I:C1511997
,	O
and	O
oxidized	B:C0003017
AGT	I:C0003017
has	O
a	O
higher	O
affinity	O
for	O
renin	O
,	O
which	O
may	O
exacerbate	O
renin-angiotensin	O
system	I:C0035096
-	O
associated	O
diseases	I:C0243083
.	O

The	O
intact	O
AGT	I:C0003017
conformation	O
exists	O
as	O
oxidized	O
AGT	I:C0003017
(	O
oxidized	O
AGT	I:C0003017
)	O
and	O
reduced	O
AGT	I:C0003017
(	O
reduced	O
AGT	I:C0003017
)	O
in	O
a	O
disulfide	O
bond	I:C1511997
,	O
and	O
oxidized	O
AGT	I:C0003017
has	O
a	O
higher	O
affinity	O
for	O
renin	B:C0035094
,	O
which	O
may	O
exacerbate	O
renin-angiotensin	O
system	I:C0035096
-	O
associated	O
diseases	I:C0243083
.	O

The	O
intact	O
AGT	I:C0003017
conformation	O
exists	O
as	O
oxidized	O
AGT	I:C0003017
(	O
oxidized	O
AGT	I:C0003017
)	O
and	O
reduced	O
AGT	I:C0003017
(	O
reduced	O
AGT	I:C0003017
)	O
in	O
a	O
disulfide	O
bond	I:C1511997
,	O
and	O
oxidized	O
AGT	I:C0003017
has	O
a	O
higher	O
affinity	O
for	O
renin	O
,	O
which	O
may	O
exacerbate	O
renin-angiotensin	B:C0035096
system	I:C0035096
-	O
associated	O
diseases	I:C0243083
.	O

The	O
intact	O
AGT	I:C0003017
conformation	O
exists	O
as	O
oxidized	O
AGT	I:C0003017
(	O
oxidized	O
AGT	I:C0003017
)	O
and	O
reduced	O
AGT	I:C0003017
(	O
reduced	O
AGT	I:C0003017
)	O
in	O
a	O
disulfide	O
bond	I:C1511997
,	O
and	O
oxidized	O
AGT	I:C0003017
has	O
a	O
higher	O
affinity	O
for	O
renin	O
,	O
which	O
may	O
exacerbate	O
renin-angiotensin	O
system	I:C0035096
-	O
associated	B:C0243083
diseases	I:C0243083
.	O

Accordingly	O
,	O
we	O
determined	O
intact	B:C0003017
AGT	I:C0003017
,	O
oxidized	O
AGT	I:C0003017
,	O
and	O
reduced	O
AGT	I:C0003017
levels	O
in	O
plasma	O
from	O
rats	O
and	O
mice	O
.	O

Accordingly	O
,	O
we	O
determined	O
intact	O
AGT	I:C0003017
,	O
oxidized	B:C0003017
AGT	I:C0003017
,	O
and	O
reduced	O
AGT	I:C0003017
levels	O
in	O
plasma	O
from	O
rats	O
and	O
mice	O
.	O

Accordingly	O
,	O
we	O
determined	O
intact	O
AGT	I:C0003017
,	O
oxidized	O
AGT	I:C0003017
,	O
and	O
reduced	B:C0003017
AGT	I:C0003017
levels	O
in	O
plasma	O
from	O
rats	O
and	O
mice	O
.	O

Accordingly	O
,	O
we	O
determined	O
intact	O
AGT	I:C0003017
,	O
oxidized	O
AGT	I:C0003017
,	O
and	O
reduced	O
AGT	I:C0003017
levels	O
in	O
plasma	B:C0032105
from	O
rats	O
and	O
mice	O
.	O

Accordingly	O
,	O
we	O
determined	O
intact	O
AGT	I:C0003017
,	O
oxidized	O
AGT	I:C0003017
,	O
and	O
reduced	O
AGT	I:C0003017
levels	O
in	O
plasma	O
from	O
rats	B:C0034693
and	O
mice	O
.	O

Accordingly	O
,	O
we	O
determined	O
intact	O
AGT	I:C0003017
,	O
oxidized	O
AGT	I:C0003017
,	O
and	O
reduced	O
AGT	I:C0003017
levels	O
in	O
plasma	O
from	O
rats	O
and	O
mice	B:C0025929
.	O

Blood	B:C0178913
samples	I:C0178913
were	O
obtained	O
by	O
cardiac	O
puncture	I:C0022885
and	O
then	O
immediately	O
mixed	O
with	O
an	O
inhibitor	O
solution	O
containing	O
a	O
renin	O
inhibitor	I:C1960108
.	O

Blood	O
samples	I:C0178913
were	O
obtained	O
by	O
cardiac	B:C0022885
puncture	I:C0022885
and	O
then	O
immediately	O
mixed	O
with	O
an	O
inhibitor	O
solution	O
containing	O
a	O
renin	O
inhibitor	I:C1960108
.	O

Blood	O
samples	I:C0178913
were	O
obtained	O
by	O
cardiac	O
puncture	I:C0022885
and	O
then	O
immediately	O
mixed	O
with	O
an	O
inhibitor	B:C0243077
solution	O
containing	O
a	O
renin	O
inhibitor	I:C1960108
.	O

Blood	O
samples	I:C0178913
were	O
obtained	O
by	O
cardiac	O
puncture	I:C0022885
and	O
then	O
immediately	O
mixed	O
with	O
an	O
inhibitor	O
solution	O
containing	O
a	O
renin	B:C1960108
inhibitor	I:C1960108
.	O

Total	O
angiotensinogen	B:C0003017
(	O
Total	O
AGT	I:C0003017
)	O
levels	O
were	O
measured	O
by	O
Total	O
AGT	I:C0003017
ELISA	O
which	O
detects	O
both	O
cleaved	O
and	O
intact	O
AGT	I:C0003017
.	O

Total	O
angiotensinogen	O
(	O
Total	B:C0003017
AGT	I:C0003017
)	O
levels	O
were	O
measured	O
by	O
Total	O
AGT	I:C0003017
ELISA	O
which	O
detects	O
both	O
cleaved	O
and	O
intact	O
AGT	I:C0003017
.	O

Total	O
angiotensinogen	O
(	O
Total	O
AGT	I:C0003017
)	O
levels	O
were	O
measured	O
by	O
Total	B:C0003017
AGT	I:C0003017
ELISA	O
which	O
detects	O
both	O
cleaved	O
and	O
intact	O
AGT	I:C0003017
.	O

Total	O
angiotensinogen	O
(	O
Total	O
AGT	I:C0003017
)	O
levels	O
were	O
measured	O
by	O
Total	O
AGT	I:C0003017
ELISA	B:C0014441
which	O
detects	O
both	O
cleaved	O
and	O
intact	O
AGT	I:C0003017
.	O

Total	O
angiotensinogen	O
(	O
Total	O
AGT	I:C0003017
)	O
levels	O
were	O
measured	O
by	O
Total	O
AGT	I:C0003017
ELISA	O
which	O
detects	B:C0442726
both	O
cleaved	O
and	O
intact	O
AGT	I:C0003017
.	O

Total	O
angiotensinogen	O
(	O
Total	O
AGT	I:C0003017
)	O
levels	O
were	O
measured	O
by	O
Total	O
AGT	I:C0003017
ELISA	O
which	O
detects	O
both	O
cleaved	B:C0205242
and	O
intact	O
AGT	I:C0003017
.	O

Total	O
angiotensinogen	O
(	O
Total	O
AGT	I:C0003017
)	O
levels	O
were	O
measured	O
by	O
Total	O
AGT	I:C0003017
ELISA	O
which	O
detects	O
both	O
cleaved	O
and	O
intact	B:C0003017
AGT	I:C0003017
.	O

intact	B:C0003017
AGT	I:C0003017
levels	O
were	O
determined	O
by	O
intact	O
AGT	I:C0003017
ELISA	O
which	O
was	O
found	O
to	O
only	O
detect	O
reduced	O
AGT	I:C0003017
.	O

intact	O
AGT	I:C0003017
levels	O
were	O
determined	O
by	O
intact	B:C0003017
AGT	I:C0003017
ELISA	O
which	O
was	O
found	O
to	O
only	O
detect	O
reduced	O
AGT	I:C0003017
.	O

intact	O
AGT	I:C0003017
levels	O
were	O
determined	O
by	O
intact	O
AGT	I:C0003017
ELISA	B:C0014441
which	O
was	O
found	O
to	O
only	O
detect	O
reduced	O
AGT	I:C0003017
.	O

intact	O
AGT	I:C0003017
levels	O
were	O
determined	O
by	O
intact	O
AGT	I:C0003017
ELISA	O
which	O
was	O
found	O
to	O
only	O
detect	B:C0442726
reduced	O
AGT	I:C0003017
.	O

intact	O
AGT	I:C0003017
levels	O
were	O
determined	O
by	O
intact	O
AGT	I:C0003017
ELISA	O
which	O
was	O
found	O
to	O
only	O
detect	O
reduced	B:C0003017
AGT	I:C0003017
.	O

Thus	O
,	O
it	O
was	O
necessary	O
to	O
treat	O
samples	B:C0178913
with	O
dithiothreitol	O
,	O
a	O
reducing	O
agent	I:C0376446
,	O
to	O
quantify	O
total	O
intact	O
AGT	I:C0003017
concentration	O
.	O

Thus	O
,	O
it	O
was	O
necessary	O
to	O
treat	O
samples	O
with	O
dithiothreitol	B:C0012789
,	O
a	O
reducing	O
agent	I:C0376446
,	O
to	O
quantify	O
total	O
intact	O
AGT	I:C0003017
concentration	O
.	O

Thus	O
,	O
it	O
was	O
necessary	O
to	O
treat	O
samples	O
with	O
dithiothreitol	O
,	O
a	O
reducing	B:C0376446
agent	I:C0376446
,	O
to	O
quantify	O
total	O
intact	O
AGT	I:C0003017
concentration	O
.	O

Thus	O
,	O
it	O
was	O
necessary	O
to	O
treat	O
samples	O
with	O
dithiothreitol	O
,	O
a	O
reducing	O
agent	I:C0376446
,	O
to	O
quantify	O
total	O
intact	B:C0003017
AGT	I:C0003017
concentration	O
.	O

Total	B:C0003017
AGT	I:C0003017
levels	O
in	O
rat	O
and	O
mouse	O
plasma	O
were	O
1,839	O
±	O
139	O
and	O
1,082	O
±	O
77	O
ng	O
/	O
ml	O
,	O
respectively	O
.	O

Total	O
AGT	I:C0003017
levels	O
in	O
rat	B:C0034693
and	O
mouse	O
plasma	O
were	O
1,839	O
±	O
139	O
and	O
1,082	O
±	O
77	O
ng	O
/	O
ml	O
,	O
respectively	O
.	O

Total	O
AGT	I:C0003017
levels	O
in	O
rat	O
and	O
mouse	B:C0025929
plasma	O
were	O
1,839	O
±	O
139	O
and	O
1,082	O
±	O
77	O
ng	O
/	O
ml	O
,	O
respectively	O
.	O

Total	O
AGT	I:C0003017
levels	O
in	O
rat	O
and	O
mouse	O
plasma	B:C0032105
were	O
1,839	O
±	O
139	O
and	O
1,082	O
±	O
77	O
ng	O
/	O
ml	O
,	O
respectively	O
.	O

intact	B:C0003017
AGT	I:C0003017
levels	O
were	O
53	O
%	O
of	O
Total	O
AGT	I:C0003017
in	O
rat	O
plasma	O
but	O
only	O
22	O
%	O
in	O
mouse	O
plasma	O
,	O
probably	O
reflecting	O
the	O
greater	O
plasma	O
renin	O
activity	O
in	O
mice	O
.	O

intact	O
AGT	I:C0003017
levels	O
were	O
53	O
%	O
of	O
Total	B:C0003017
AGT	I:C0003017
in	O
rat	O
plasma	O
but	O
only	O
22	O
%	O
in	O
mouse	O
plasma	O
,	O
probably	O
reflecting	O
the	O
greater	O
plasma	O
renin	O
activity	O
in	O
mice	O
.	O

intact	O
AGT	I:C0003017
levels	O
were	O
53	O
%	O
of	O
Total	O
AGT	I:C0003017
in	O
rat	B:C0034693
plasma	O
but	O
only	O
22	O
%	O
in	O
mouse	O
plasma	O
,	O
probably	O
reflecting	O
the	O
greater	O
plasma	O
renin	O
activity	O
in	O
mice	O
.	O

intact	O
AGT	I:C0003017
levels	O
were	O
53	O
%	O
of	O
Total	O
AGT	I:C0003017
in	O
rat	O
plasma	B:C0032105
but	O
only	O
22	O
%	O
in	O
mouse	O
plasma	O
,	O
probably	O
reflecting	O
the	O
greater	O
plasma	O
renin	O
activity	O
in	O
mice	O
.	O

intact	O
AGT	I:C0003017
levels	O
were	O
53	O
%	O
of	O
Total	O
AGT	I:C0003017
in	O
rat	O
plasma	O
but	O
only	O
22	O
%	O
in	O
mouse	B:C0025929
plasma	O
,	O
probably	O
reflecting	O
the	O
greater	O
plasma	O
renin	O
activity	O
in	O
mice	O
.	O

intact	O
AGT	I:C0003017
levels	O
were	O
53	O
%	O
of	O
Total	O
AGT	I:C0003017
in	O
rat	O
plasma	O
but	O
only	O
22	O
%	O
in	O
mouse	O
plasma	B:C0032105
,	O
probably	O
reflecting	O
the	O
greater	O
plasma	O
renin	O
activity	O
in	O
mice	O
.	O

intact	O
AGT	I:C0003017
levels	O
were	O
53	O
%	O
of	O
Total	O
AGT	I:C0003017
in	O
rat	O
plasma	O
but	O
only	O
22	O
%	O
in	O
mouse	O
plasma	O
,	O
probably	O
reflecting	O
the	O
greater	O
plasma	B:C0032105
renin	O
activity	O
in	O
mice	O
.	O

intact	O
AGT	I:C0003017
levels	O
were	O
53	O
%	O
of	O
Total	O
AGT	I:C0003017
in	O
rat	O
plasma	O
but	O
only	O
22	O
%	O
in	O
mouse	O
plasma	O
,	O
probably	O
reflecting	O
the	O
greater	O
plasma	O
renin	B:C0035094
activity	O
in	O
mice	O
.	O

intact	O
AGT	I:C0003017
levels	O
were	O
53	O
%	O
of	O
Total	O
AGT	I:C0003017
in	O
rat	O
plasma	O
but	O
only	O
22	O
%	O
in	O
mouse	O
plasma	O
,	O
probably	O
reflecting	O
the	O
greater	O
plasma	O
renin	O
activity	B:C0243102
in	O
mice	O
.	O

intact	O
AGT	I:C0003017
levels	O
were	O
53	O
%	O
of	O
Total	O
AGT	I:C0003017
in	O
rat	O
plasma	O
but	O
only	O
22	O
%	O
in	O
mouse	O
plasma	O
,	O
probably	O
reflecting	O
the	O
greater	O
plasma	O
renin	O
activity	O
in	O
mice	B:C0025929
.	O

The	O
ratios	O
of	O
oxidized	B:C0003017
AGT	I:C0003017
and	O
reduced	O
AGT	I:C0003017
were	O
∼	O
4:1	O
(	O
rat	O
)	O
and	O
16:1	O
(	O
mouse	O
)	O
.	O

The	O
ratios	O
of	O
oxidized	O
AGT	I:C0003017
and	O
reduced	B:C0003017
AGT	I:C0003017
were	O
∼	O
4:1	O
(	O
rat	O
)	O
and	O
16:1	O
(	O
mouse	O
)	O
.	O

The	O
ratios	O
of	O
oxidized	O
AGT	I:C0003017
and	O
reduced	O
AGT	I:C0003017
were	O
∼	O
4:1	O
(	O
rat	B:C0034693
)	O
and	O
16:1	O
(	O
mouse	O
)	O
.	O

The	O
ratios	O
of	O
oxidized	O
AGT	I:C0003017
and	O
reduced	O
AGT	I:C0003017
were	O
∼	O
4:1	O
(	O
rat	O
)	O
and	O
16:1	O
(	O
mouse	B:C0025929
)	O
.	O

Plasma	B:C0032105
intact	O
AGT	I:C0003017
consists	O
of	O
oxidized	O
AGT	I:C0003017
and	O
reduced	O
AGT	I:C0003017
,	O
suggesting	O
that	O
oxidative	O
stress	I:C0242606
can	O
influence	O
angiotensin	O
I	I:C0003006
generation	O
by	O
the	O
angiotensinogen	O
conformation	O
switch	O
.	O

Plasma	O
intact	B:C0003017
AGT	I:C0003017
consists	O
of	O
oxidized	O
AGT	I:C0003017
and	O
reduced	O
AGT	I:C0003017
,	O
suggesting	O
that	O
oxidative	O
stress	I:C0242606
can	O
influence	O
angiotensin	O
I	I:C0003006
generation	O
by	O
the	O
angiotensinogen	O
conformation	O
switch	O
.	O

Plasma	O
intact	O
AGT	I:C0003017
consists	O
of	O
oxidized	B:C0003017
AGT	I:C0003017
and	O
reduced	O
AGT	I:C0003017
,	O
suggesting	O
that	O
oxidative	O
stress	I:C0242606
can	O
influence	O
angiotensin	O
I	I:C0003006
generation	O
by	O
the	O
angiotensinogen	O
conformation	O
switch	O
.	O

Plasma	O
intact	O
AGT	I:C0003017
consists	O
of	O
oxidized	O
AGT	I:C0003017
and	O
reduced	B:C0003017
AGT	I:C0003017
,	O
suggesting	O
that	O
oxidative	O
stress	I:C0242606
can	O
influence	O
angiotensin	O
I	I:C0003006
generation	O
by	O
the	O
angiotensinogen	O
conformation	O
switch	O
.	O

Plasma	O
intact	O
AGT	I:C0003017
consists	O
of	O
oxidized	O
AGT	I:C0003017
and	O
reduced	O
AGT	I:C0003017
,	O
suggesting	O
that	O
oxidative	B:C0242606
stress	I:C0242606
can	O
influence	O
angiotensin	O
I	I:C0003006
generation	O
by	O
the	O
angiotensinogen	O
conformation	O
switch	O
.	O

Plasma	O
intact	O
AGT	I:C0003017
consists	O
of	O
oxidized	O
AGT	I:C0003017
and	O
reduced	O
AGT	I:C0003017
,	O
suggesting	O
that	O
oxidative	O
stress	I:C0242606
can	O
influence	O
angiotensin	B:C0003006
I	I:C0003006
generation	O
by	O
the	O
angiotensinogen	O
conformation	O
switch	O
.	O

Plasma	O
intact	O
AGT	I:C0003017
consists	O
of	O
oxidized	O
AGT	I:C0003017
and	O
reduced	O
AGT	I:C0003017
,	O
suggesting	O
that	O
oxidative	O
stress	I:C0242606
can	O
influence	O
angiotensin	O
I	I:C0003006
generation	O
by	O
the	O
angiotensinogen	B:C0003017
conformation	O
switch	O
.	O

Plasma	O
intact	O
AGT	I:C0003017
consists	O
of	O
oxidized	O
AGT	I:C0003017
and	O
reduced	O
AGT	I:C0003017
,	O
suggesting	O
that	O
oxidative	O
stress	I:C0242606
can	O
influence	O
angiotensin	O
I	I:C0003006
generation	O
by	O
the	O
angiotensinogen	O
conformation	B:C0033625
switch	O
.	O

Furthermore	O
,	O
the	O
lower	O
availability	O
of	O
plasma	B:C0032105
intact	O
AGT	I:C0003017
in	O
mice	O
suggests	O
that	O
it	O
may	O
serve	O
as	O
a	O
limiting	O
factor	O
in	O
angiotensin	O
I	I:C0003006
formation	O
in	O
this	O
species	O
.	O

Furthermore	O
,	O
the	O
lower	O
availability	O
of	O
plasma	O
intact	B:C0003017
AGT	I:C0003017
in	O
mice	O
suggests	O
that	O
it	O
may	O
serve	O
as	O
a	O
limiting	O
factor	O
in	O
angiotensin	O
I	I:C0003006
formation	O
in	O
this	O
species	O
.	O

Furthermore	O
,	O
the	O
lower	O
availability	O
of	O
plasma	O
intact	O
AGT	I:C0003017
in	O
mice	B:C0025929
suggests	O
that	O
it	O
may	O
serve	O
as	O
a	O
limiting	O
factor	O
in	O
angiotensin	O
I	I:C0003006
formation	O
in	O
this	O
species	O
.	O

Furthermore	O
,	O
the	O
lower	O
availability	O
of	O
plasma	O
intact	O
AGT	I:C0003017
in	O
mice	O
suggests	O
that	O
it	O
may	O
serve	O
as	O
a	O
limiting	O
factor	O
in	O
angiotensin	B:C0003006
I	I:C0003006
formation	O
in	O
this	O
species	O
.	O

Furthermore	O
,	O
the	O
lower	O
availability	O
of	O
plasma	O
intact	O
AGT	I:C0003017
in	O
mice	O
suggests	O
that	O
it	O
may	O
serve	O
as	O
a	O
limiting	O
factor	O
in	O
angiotensin	O
I	I:C0003006
formation	O
in	O
this	O
species	B:C1705920
.	O

